Brandon S. Sheffield
Brandon S. Sheffield
William Osler Health System
Verified email at
Cited by
Cited by
New markers for separating benign from malignant mesothelial proliferations: are we there yet?
A Churg, BS Sheffield, F Galateau-Salle
Archives of Pathology and Laboratory Medicine 140 (4), 318-321, 2016
BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations
BS Sheffield, HC Hwang, AF Lee, K Thompson, S Rodriguez, CH Tse, ...
The American journal of surgical pathology 39 (7), 977-982, 2015
Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens
HC Hwang, BS Sheffield, S Rodriguez, K Thompson, CH Tse, AM Gown, ...
The American journal of surgical pathology 40 (1), 120-126, 2016
Synchronous endometrial and ovarian carcinomas: evidence of clonality
MS Anglesio, YK Wang, M Maassen, HM Horlings, A Bashashati, J Senz, ...
JNCI: Journal of the National Cancer Institute 108 (6), 2016
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing
BS Sheffield, AV Tinker, Y Shen, H Hwang, HH Li-Chang, E Pleasance, ...
PloS one 10 (3), e0119689, 2015
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma
M Riazy, SE Kalloger, BS Sheffield, RD Peixoto, HH Li-Chang, ...
Modern Pathology 28 (10), 1383-1389, 2015
Preoperative diagnosis of thyroid nodules using the Bethesda System for Reporting Thyroid Cytopathology: a comprehensive review and meta-analysis
BS Sheffield, H Masoudi, B Walker, SM Wiseman
Expert review of endocrinology & metabolism 9 (2), 97-110, 2014
HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation
BS Sheffield, J Garratt, SE Kalloger, HH Li-Chang, EE Torlakovic, ...
Archives of Pathology and Laboratory Medicine 138 (11), 1495-1502, 2014
Challenges in making the transition between pediatric and adult eating disorder programs: a qualitative study from the perspective of service providers
G Dimitropoulos, AF Tran, P Agarwal, B Sheffield, B Woodside
Eating disorders 21 (1), 1-15, 2013
Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer
BS Sheffield, R Fulton, SE Kalloger, K Milne, G Geller, M Jones, ...
Journal of Histochemistry & Cytochemistry 64 (10), 587-600, 2016
Navigating the transition from pediatric to adult eating disorder programs: Perspectives of service providers
G Dimitropoulos, AF Tran, P Agarwal, B Sheffield, B Woodside
International Journal of Eating Disorders 45 (6), 759-767, 2012
Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective
M Cabanero, R Sangha, BS Sheffield, M Sukhai, M Pakkal, S Kamel-Reid, ...
Current Oncology 24 (2), 111, 2017
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
BS Sheffield, Z Kos, K Asleh-Aburaya, XQ Wang, S Leung, D Gao, J Won, ...
Breast cancer research and treatment 155 (3), 483-490, 2016
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
MR Jones, KA Schrader, Y Shen, E Pleasance, C Ch'ng, N Dar, S Yip, ...
Annals of Oncology 27 (5), 801-806, 2016
Loss of BRCA1-associated Protein 1 (BAP1) expression is rare in non–small cell lung cancer
D Owen, BS Sheffield, D Ionescu, A Churg
Human pathology 60, 82-85, 2017
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma
B Tessier-Cloutier, SE Kalloger, M Al-Kandari, K Milne, D Gao, BH Nelson, ...
BMC cancer 17 (1), 618, 2017
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice
LM Prentice, RR Miller, J Knaggs, A Mazloomian, R Aguirre Hernandez, ...
PloS one 13 (4), e0196434, 2018
Immunohistochemistry as a practical tool in molecular pathology
BS Sheffield
Archives of pathology & laboratory medicine 140 (8), 766-769, 2016
Integrative genomic analysis of ghost cell odontogenic carcinoma.
P Bose, ED Pleasance, M Jones, Y Shen, C Ch'ng, C Reisle, JE Schein, ...
Oral oncology 51 (9), e71, 2015
Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ fails to separate benign from malignant mesothelial proliferations
BS Sheffield, J Lorette, Y Shen, MA Marra, A Churg
Archives of Pathology & Laboratory Medicine 140 (5), 391-391, 2016
The system can't perform the operation now. Try again later.
Articles 1–20